The Mechanism Exploration of Natural Medicines in Treating Cardiovascular Diseases Based on Network Pharmacology

Abstract Cardiovascular diseases (CVDs), including atherosclerosis, congestive heart failure, and hypertension, are most commonly observed in middle-aged and elderly individuals. Approximately 15 million people die from them every year worldwide. CVDs are associated with high morbidity, disability, and mortality rates, posing a significant threat to public health. Although the importance of natural medicines in treating CVDs has become increasingly prominent, there is still much to be discovered about their composition and mechanisms of action. With the rise of network pharmacology as a valuable tool to understand how natural medicines work, researchers can study the body's responses to disease stimuli and drug therapy by constructing a “component–target–pathway–disease” interaction network. In this work, we summarized the application of network pharmacology in the study of CVDs. We also discussed the challenges and opportunities by this tools, hoping to provide suggestions for the treatment of the disease in the future.

Authors

Institutions

Publication Details

Journal
Pharmaceutical Fronts
Published
2026-02-26
DOI
https://doi.org/10.1055/a-2793-3881
Primary Topic
Bioinformatics and Genomic Networks
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Mechanism Exploration of Natural Medicines in Treating Cardiovascular Diseases Based on Network Pharmacology

Yi Jin, Xucong Huang, BuYong Ma, Qiangqiang Yu et al.
Pharmaceutical Fronts
Bioinformatics and Genomic Networks
article

The Mechanism Exploration of Natural Medicines in Treating Cardiovascular Diseases Based on Network Pharmacology

Yi Jin, Xucong Huang, BuYong Ma, Qiangqiang Yu, Rui Xu, Xiaobo Li, Kunwei Li, Weiying Wang
article en

Abstract

Abstract Cardiovascular diseases (CVDs), including atherosclerosis, congestive heart failure, and hypertension, are most commonly observed in middle-aged and elderly individuals. Approximately 15 million people die from them every year worldwide. CVDs are associated with high morbidity, disability, and mortality rates, posing a significant threat to public health. Although the importance of natural medicines in treating CVDs has become increasingly prominent, there is still much to be discovered about their composition and mechanisms of action. With the rise of network pharmacology as a valuable tool to understand how natural medicines work, researchers can study the body's responses to disease stimuli and drug therapy by constructing a “component–target–pathway–disease” interaction network. In this work, we summarized the application of network pharmacology in the study of CVDs. We also discussed the challenges and opportunities by this tools, hoping to provide suggestions for the treatment of the disease in the future.

Pharmaceutical FrontsVol. 08(01)
Shanghai Jiao Tong University (CN)
National Natural Science Foundation of China
Good health and well-being
Openalex Percentile: Top 41%
Bioinformatics and Genomic Networks
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.